Skip to main content

Activation of an HIV-LTR-CAT Transgene in Murine Macrophages by Interferon-γ in Synergism with other Cytokines or Endotoxin

  • Chapter
Dendritic Cells in Fundamental and Clinical Immunology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 378))

  • 32 Accesses

Abstract

The initial infection with human immunodeficiency virus (HIV) and early viremia are usually caused by macrophage (MΦ)-tropic and non-syncytium- inducing HIV variants, while syncytium-inducing T cell infecting HIV arise later in the disease (1). Therefore, factors that influence the propagation of HIV within MΦs may be critical in determining the progression of AIDS. Among the cytokines frequently elevated in HIV+ patients and capable of influencing MΦ functions are IFN-γ, IL-6, TNF-α and TGF-ß (2–5). Secondary infections with gram negative organisms common in HIV patients are probably sources of LPS. The purpose of the present investigation was to identify modulatory factors that suppress and/or activate the HIV genome within MΦs in a noninfectious animal model and to study their mechanism of action. Transgenic FVB/N mice homozygous for the LTR sequence (-453/+80) which contains the transcriptional regulatory elements of HIV linked to the bacterial gene encoding CAT as the reporter gene were used as an experimental model (6). Thus, alterations in HIV-LTR directed expression of CAT would be analogous to changes in viral expression in cells harboring integrated virus. Results from studies on the influence of biological response modifiers (BRMs) and UV-irradiation on HIV-LTRCAT expression in MΦs and/or epidermis indicate the usefulness of this animal model (6–9), particularly when compared with those obtained with HIV-LTR (with or without Tat) transfected human MΦs (10).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. H. Schuitemaker, M. Koot, N. A. Kootstra, M. W. Dercksen, R.E.Y. DeGoede, R. P. Van Steenwijk, J.M.A. Lange, O.K.M.E. Schattenkerk, F. Miedema, and M. Tersmette, Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354(1992).

    PubMed  CAS  Google Scholar 

  2. D.E. Griffin, J.C. McArthur, and D.R. Cornblath, Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 41:69(1991).

    Article  PubMed  CAS  Google Scholar 

  3. B. Lahdevirta, C.P.J. Maury, A.M. Teppo, and H. Repo. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. O. Med. 85:289(1988).

    Article  CAS  Google Scholar 

  4. E.C. Breen, A.R. Rezai, K. Nakajima, G.N. Beall, R.T. Mitsuyasu, T. Hirano, T.Kishimoto, and O. Martinez-Maza, Infection with HIV is associated with elevated IL-6 levels and production. O. Immunol. 144:480(1990).

    CAS  Google Scholar 

  5. J. Kekow, W. Wachsman, B. A. McCutchan, M. Cronin, D.A. Carson, and M. Lotz,Transforming growth factor ß and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 87:8321(1990).

    Article  PubMed  CAS  Google Scholar 

  6. B. Leonard, J.S. Khillan, H.E. Gendelman, A. Adachi, S. Lorenzo, H. Westphal, M.A.Martin, and M.S. Meltzer. The human immunodeficiency virus long terminal repeat is preferentially expressed in langerhans cells in transgenic mice. AIDS Res. Hum. Retroviruses 5:421(1989).

    Article  PubMed  CAS  Google Scholar 

  7. Frucht, D.M., L. Lamperth, E. Vicenzi, J.H. Belcher, and M.A. Martin. Ultraviolet radiation increases HIV-Long terminal repeat-directed expression in transgenic mice. AIDS Res. Hum. Retroviruses 7:719(1991).

    Article  Google Scholar 

  8. Warfel, A.H., G.J. Thorbecke, and D.V. Belsito. Cytokine and LPS induced CAT activation in macrophages (Md) from transgenic mice carrying the LTR-(CAT) sequence of HIV. 3. Immunol. 150:317A(1993).

    Google Scholar 

  9. Warfel, A.H., J.A. Moy, T. Meola, M. Sanchez, N. Soter, and D.V. Belsito. Effect of ultraviolet B (UVB) on the expression of human immunodeficiency virus (HIV) in mice and humans. Photochem. Photobiol. 57:75S(1993).

    Google Scholar 

  10. Moses, A.V., C. Ibanez, R. Gaynor, P. Ghazal, and J.A. Nelson. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. J. Virol. 68:298(1994).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Warfel, A.H., Belsito, D.V., Thorbecke, G.J. (1995). Activation of an HIV-LTR-CAT Transgene in Murine Macrophages by Interferon-γ in Synergism with other Cytokines or Endotoxin. In: Banchereau, J., Schmitt, D. (eds) Dendritic Cells in Fundamental and Clinical Immunology. Advances in Experimental Medicine and Biology, vol 378. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1971-3_110

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1971-3_110

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5811-4

  • Online ISBN: 978-1-4615-1971-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics